Is Dow Inc. a Buy?

06/14/2019

It may have kept the same recognizable stock ticker, but the Dow Inc. (NYSE: DOW) that investors see on financial dashboards today is a completely […]

Is Axovant Gene Therapies a Buy?

06/10/2019

The legacy of Axovant Gene Therapies (NASDAQ: AXGT) is one of disappointment. The business soared to a market capitalization of $2.4 billion in mid-2017 on […]